University of California
Irvine, California, 92697, United States
NCT Number: NCT04969380
Open-label, non-randomized, prospective, multi-center, self-controlled clinical study with masked evaluation.
Looking for future studies?
Notify Me35 year–80 year
All sexes
Interventional
Not applicable
Irvine, California, 92697, United States
Eligible patients will receive 2 face and neck treatments (4-6 weeks ± 2 weeks apart) using the SofWave System. Each investigational site would treat the full face and submental zones including 1. The forehead and temples (left and right including the peri orbital zone) to lift the eyebrows 2. The cheeks (left and right including perioral zone and nasolabial folds) 3. Submental and sides of the neck (left and right) to lift lax skin.
All patients will return to the clinic for two follow up visits: 1. 7 days (FU1) post the first treatment (Tx.1). 2. 3 months ± 2 weeks post last treatment (FU2).
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The Sofwave System, comprised of an applicator and a console, generates high intensity, non-focused ultrasonic energy which can be delivered percutaneously to tissues.
Time frame: 3 and 6 months post last treatment
As assessed by independent masked evaluators. Quantitative image analysis to objectively measure change in lift of the eyebrow and submental and neck lax tissue would be conducted by comparing baseline images to those taken at each visit post FU1 (Pre Tx.2, FU2)
Sofwave Medical LTD
Industry
Safety and Efficacy of Sofacia Treatment to Improve Facial Lines and Wrinkles, to Lift Lax Tissue in the Submental and Neck Zones and to Lift the Eyebrow
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06724510
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases
Beijing, China
View Trial DetailsNCT06351358
Body Weight, Body Weight Changes
Washington D.C., District of Columbia, United States
View Trial DetailsNCT06243744
Collagen Degeneration, Collagen Shrinkage
Bradenton, Florida, United States
View Trial DetailsNCT07255560
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Connective Tissue Diseases
Valencia, Spain
View Trial Details